Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-diethylaminoethyl-3-phenyl-1,2,4-oxadiazole
2. Bredon
3. Oxobron
4. Oxolamine Citrate
5. Oxolamine Monohydrochloride
1. 959-14-8
2. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine
3. Oxolamina
4. Oksalamin
5. 683 M
6. Af 438
7. Oxadiazole; 683m
8. 5-(2-diethylaminoethyl)-3-phenyl-1,2,4-oxadiazole
9. Af-438 Free Base
10. N,n-diethyl-3-phenyl-1,2,4-oxadiazole-5-ethanamine
11. 90bea145gy
12. Skf 9976 Free Base
13. Skf-9976 Free Base
14. Af-438 [as Citrate]
15. Oxolamine (inn)
16. Skf 9976 [as Citrate]
17. 5-(2-dietilaminoetil)-3-fenil-1,2,4-oxadiazolo
18. Oxolamine [inn]
19. Oxolev
20. Jatan
21. 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl-
22. Oxolev A
23. Ossolamina [dcit]
24. Oxolamina [italian]
25. Ossolamina
26. Oxolaminum
27. Oxolamine [inn:dcf]
28. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethan-1-amine
29. Oxolaminum [inn-latin]
30. Oxolamina [inn-spanish]
31. Einecs 213-493-4
32. Brn 0527181
33. Unii-90bea145gy
34. Oksalamin (tn)
35. 3-phenyl-5-(beta-diethylaminoethyl)-1,2,4-oxodiazole
36. 5-(2-dietilaminoetil)-3-fenil-1,2,4-oxadiazolo [italian]
37. Oxolamine [mi]
38. Prestwick0_000826
39. Prestwick1_000826
40. Prestwick2_000826
41. Prestwick3_000826
42. Oxolamine [mart.]
43. Ec 213-493-4
44. Oxolamine [who-dd]
45. Bspbio_000751
46. Schembl893333
47. Spbio_002672
48. Bpbio1_000827
49. Zinc1874
50. 1,2,4-oxadiazole-5-ethanamine, N,n-diethyl-3-phenyl-
51. Chembl1620875
52. Dtxsid5023403
53. Chebi:94607
54. Db13216
55. Ncgc00179449-01
56. Sbi-0207016.p001
57. Ft-0748644
58. D07387
59. 959o148
60. Q576684
61. Brd-k42596464-048-03-6
62. 3-phenyl-5-(.beta.-diethylaminoethyl)-1,2,4-oxodiazole
63. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine 2-hydroxy-1,2,3-propanetricarboxylate
Molecular Weight | 245.32 g/mol |
---|---|
Molecular Formula | C14H19N3O |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 245.152812238 g/mol |
Monoisotopic Mass | 245.152812238 g/mol |
Topological Polar Surface Area | 42.2 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 227 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
R - Respiratory system
R05 - Cough and cold preparations
R05D - Cough suppressants, excl. combinations with expectorants
R05DB - Other cough suppressants
R05DB07 - Oxolamine
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?